Is clinician impression of depression symptom severity associated with incremental economic burden in privately insured US patients with treatment resistant depression?

摘要

Background: Among patients with major depressive disorder (MDD), those with treatment-resistant depression (TRD) have a higher economic burden. However, the healthcare resource utilization (HRU) and costs may vary by severity status in TRD patients. This study quantified the incremental economic burden of severity status in TRD patients.